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A small-angle X-ray scattering 
study of alpha-synuclein from 
human red blood cells
Katsuya Araki1, Naoto Yagi2, Rie Nakatani1, Hiroshi Sekiguchi2, Masatomo So3, Hisashi Yagi4, 
Noboru Ohta2, Yoshitaka Nagai5, Yuji Goto3 & Hideki Mochizuki1
α-synuclein (α-syn) is the main component of Lewy bodies, which are neuropathological hallmarks of 
patients with Parkinson’s disease. As it has been controversial whether human α-syn from erythrocytes 
exists as a tetramer under physiological conditions, we tried solving this issue by the small-angle 
X-ray solution scattering method. Under two different conditions (high ionic strength with a Tris buffer 
and low ionic strength with an ammonium acetate buffer), no evidence was found for the presence of 
tetramer. When comparing erythrocyte and recombinant α-syn molecules, we found no significant 
difference of the molecular weight and the secondary structure although the buffer conditions strongly 
affect the radius of gyration of the protein. The results indicate that, even though a stable tetramer may 
not be formed, conformation of α-syn depends much on its environment, which may be the reason for 
its tendency to aggregate in cells.
α -synuclein (α -syn) is the main component of Lewy bodies, which are neuropathological hallmarks of patients 
with Parkinson’s disease and dementia with Lewy body1,2. In Lewy bodies, α -syn has a fibril-like structure3,4. 
α -syn is highly expressed in central nervous system5–7 and erythrocyte8, but its function is obscure. Many struc-
tural analyses, such as circular dichroism, Fourier transform infrared spectroscopy, small angle X-ray scatter-
ing (SAXS), revealed that α -syn exists as an intrinsically disordered monomer of about 14.46 kDa9–11. For these 
measurements, recombinant human α -syn purified from Escherichia coli (E. coli) which has a non-acetylated 
N-terminal has been used. In 2011, Bartels et al. reported that α -syn purified from human red blood cells (RBCs) 
and cultured cells exists as a stable tetramer that resists aggregation12. To study the state of endogenous α -syn in 
living human cells, they used α -syn prepared from RBCs. Then, Wang et al. also reported that α -syn purified from 
E. coli in non-denaturing conditions is a dynamic tetramer13. Furthermore, Trexler et al. showed that N-terminal 
acetylation is critical for formation of α -helical oligomers of α -syn14. Some papers reported that N-terminal 
modification or its interaction with lipid menbranes, may change the structure and aggregation of α -syn15,16. In 
contrast, in 2012, Fauvet, et al. reported that α -syn in central nervous system, erythrocytes, and mammalian cells 
exists predominantly as a disordered monomer17. They also reported that N-terminal acetylation of α -syn does 
not dramatically affect its structure or oligomerization state in vitro and in intact cells18. Some of these experi-
ments were performed under different buffer conditions. Although the presence of tetramer may be arguable19, 
the state of non-recombinant α -syn, particularly from RBCs, in solution has not been characterized.
In this study, we examined the oligomeric state of α -syn from human RBCs with SAXS and compared it to 
recombinant human α -syn expressed in E. coli under different buffer conditions.
Results
Characterization of the proteins. The purity of the proteins was confirmed by SDS-PAGE and MALDI 
mass spectroscopy (Fig. 1a,b). They confirmed that the proteins were of high enough purity and that α -syn from 
human RBC (RBC) was likely to be N-terminally acetylated in terms of molecular weight12.
1Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, 
Japan. 2Japan Synchrotron Radiation Research Institute (JASRI), SPring-8, 1-1-1 Kouto, Sayo, Sayo, Hyogo 679-5198, 
Japan. 3Institute for Protein Research, Osaka University, 3-2 Yamadaoka, Suita, Osaka 565-0871, Japan. 4Center for 
Research on Green Sustainable Chemistry, Tottori University, 4-101 Koyamacho-minami, Tottori, Tottori 680-8550, 
Japan. 5Department of Neurotherapeutics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, 
Osaka 565-0871, Japan. Correspondence and requests for materials should be addressed to N.Y. (email: yagi@
spring8.or.jp) or H.M. (email: hmochizuki@neurol.med.osaka-u.ac.jp)
received: 12 May 2016
accepted: 05 July 2016
Published: 29 July 2016
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 6:30473 | DOI: 10.1038/srep30473
Circular dichroism (CD) spectra of the proteins in the AA buffer (10 mM Ammonium acetate (pH 7.4)) and 
the Tris buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl) are shown in Fig. 1c,d, respectively. The spectra of 
recombinant wild type α -syn (WT α -syn) showed typical random coil profiles in both buffers. Similarly, those of 
N-terminally acetylated recombinant α -syn (NAc α -syn) also showed typical random coil profiles in both buff-
ers. On the other hand, while the spectrum of α -syn purified from human RBC (RBC α -syn) showed a typical 
random coil profile in the AA buffer (Fig. 1c), it suggested the presence of secondary structure, although difficult 
to analyze in detail, in the Tris buffer (Fig. 1d).
Static SAXS measurements. Typical X-ray scattering intensity curves at four different concentrations of 
RBC α -syn in the Tris buffer are shown in Fig. 2a. The Guinier plot and the linear fitting is shown in Fig. 2b. The 
concentration dependence of the radius of gyration (Rg) is plotted in Fig. 3a. When extrapolated to zero concen-
tration, the Rg value was 3.31 ± 0.30 nm (mean ± standard deviation, n = 4). In the AA buffer, which was used by 
Bartels et al.12, Rg was 3.33 ± 0.10 nm (n = 2). Although difference in the CD spectrum (Fig. 1c,d) suggests confor-
mational difference in the two buffers, the Rg values were similar, showing that formation of secondary structure 
does not affect the flexibility or extensibility of the protein.
The I(0)/c (c is protein concentration) values normalized to that of lysozyme, which has a molecular weight 
(14.3 kDa) similar to α -syn, were 1.14 ± 0.40 (n = 4) in the Tris buffer and 0.94 ± 0.03 (n = 2) in the AA buffer, 
showing that the protein is monomeric in both buffers.
Typical X-ray scattering intensity curves of recombinant wild type (WT) α -syn in the Tris buffer are shown 
in Fig. 2c with a Guinier fit in Fig. 2d. From extrapolation to the zero concentration (Fig. 3a), the Rg value was 
obtained as 4.27 ± 0.37 nm (n = 7). Compared with RBC α -syn, the region where a linear fit was available in the 
Figure 1. (a) SDS-PAGE/Coomassie Brilliant Blue (or silver) staining. WT, NAc and RBC represents wildtype 
α -syn, N-terminally acetylated α -syn and α -syn purified from human RBCs, respectively. (b) MALDI spectra of 
α -syn. Theoretical molecular weights (MWs) of Wild type (WT) and N-terminally acetylated (NAc) are 14460 
and 14502, respectively. RBC represents α -syn purified from human RBCs. (c) Circular dichroism spectra of 
WT, NAc and RBC in the AA buffer (10 mM ammonium acetate (pH 7.4)). (d) Circular dichroism spectra of 
WT, NAc and RBC in the Tris buffer (50 mM Tris-HCl, 150 mM NaCl (pH 7.4))
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Guinier plot was narrower. Typical X-ray scattering intensity curves of recombinant WT α -syn in the AA buffer 
are shown in Fig. 2e with a Guinier fit in Fig. 2f. In the AA buffer, Rg was found to be smaller, 2.72 ± 0.44 nm 
(n = 3). The I(0)/c values normalized by that of lysozyme were 1.58 ± 0.53 (n = 7) in the Tris buffer and 1.06 ± 0.07 
(n = 3) in the AA buffer.
Since α -syn prepared from RBCs has acetylated N-terminus (Fig. 1), N-terminus of recombinant α -syn 
was acetylated to find if the difference in the SAXS results between RBC and recombinant α -syn is due to this 
modification. The Rg value of N-terminally acetylated recombinant α -syn (NAc) was 4.04 ± 0.22 nm (n = 4) and 
3.09 ± 0.18 nm (n = 2) in the Tris and AA buffers, respectively. The I(0)/c values were 1.34 ± 0.15 and 0.99 ± 0.19 
in the Tris and AA buffers, respectively. These results are summarized in Table 1.
Figure 2. (a) A typical set of SAXS profiles from human RBC α -syn at four different concentrations. (b) Guinier 
plots of the data in (a). (c) A typical set of SAXS profiles from WT α -syn in the Tris buffer at four different 
concentrations. (d) Guinier plots of the data in (d). (e) A typical set of SAXS profiles from WT α -syn in the AA 
buffer at three different concentrations. (f) Guinier plots of the data in (e).
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SEC-SAXS. In the static SAXS experiment, small-angle scattering curves from recombinant WT α -syn in the 
Tris buffer had only a limited region that can be used for the Guinier analysis (Fig. 2c,d). The intensity in the very 
small angle region (q < 0.2 nm−1) was steeper than that from RBC α -syn, suggesting the presence of oligomers 
or aggregates. To remove these large particles, measurements were made with proteins after passing through a 
size-exclusion column. Since the amount of protein that can be prepared from RBCs is small, the measurement 
was made only with recombinant α -syn. The SAXS measurement was made continuously during protein elution 
and a profile was obtained by summing data acquired when the protein concentration was more than half of its 
peak (Fig. 4a). The Rg value was 3.59 ± 0.14 nm (5 separate experiments). The scattering curve (Fig. 4b) was more 
similar to that of RBC α -syn obtained in the static experiments than that of recombinant proteins (Table 1). With 
N-terminally acetylated recombinant α -syn, Rg was found to be 3.59 ± 0.28 nm (n = 2).
Discussion
In this study, we prepared α -syn from RBCs following the procedure by Fauvet et al.17. The SAXS measurements 
were made in the buffer condition (the low ionic-strength AA buffer) in which they found tetramers. At the 
concentration commonly used for the SAXS measurements (a few mg/ml), we found that the protein was mon-
omeric. With both the Tris and the AA buffers and with RBC and recombinant α -syn preparations, no evidence 
was obtained that suggested the presence of tetramers. These results are in accordance with those of Fauvet et al.17  
who found that RBC α -syn is monomeric. It also agrees with a more recent report that α -syn predominantly 
exists as a monomer in a living cell20.
The two α -syn preparations used in this study, one from RBCs and the N-terminally acetylated one cloned and 
expressed in E. coli, share the same amino acid sequence of human α -syn and N-terminus acetylation. However, 
the physical characteristics of these preparations were clearly different. RBC α -syn had a smaller Rg than the 
recombinant N-terminally acetylated α -syn in the Tris buffer (Table 1). This may be due to a rather harsh prepa-
ration method of the recombinant protein which involves heating up to 90 °C. In fact, it has been shown that 
recombinant α -syn (with extra 10 residues at the N-terminus) purified without heat denaturation was found 
more disordered with CD and NMR (Wang et al.)13. Heat treatment may cause irreversible effects on the α -syn 
structure.
The X-ray scattering curves of the recombinant α -syn, both WT and N-terminally acetylated, had a narrower 
linear region compared with the RBC α -syn (Fig. 2c), suggesting it may be a mixture of different conformations 
or oligomers. Indeed, with a size-exclusion chromatography, the scattering curve became more like one from a 
Figure 3. (a) Concentration dependence of the Rg values in three types of α -syn. The value at the abscissa was 
used as the Rg value at infinite dilution. (b) Concentration dependence of the I(0)/c value.
static SAXS SEC-SAXS
WT NAc RBC WT NAc
Tris buffer
mean 4.27 4.04 3.31 3.59 3.59
SD 0.37 0.22 0.3 0.14 0.28
n 7 4 4 5 2
AA buffer
mean 2.72 3.09 3.33
SD 0.44 0.18 0.10
n 3 2 2
Table 1.  Summary of results on Rg measurements (in nm). WT, NAc and RBC represent wild type α -syn, 
N-terminally acetylated α -syn and α -syn purified from human RBCs, respectively.
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monodisperse preparation and the Rg value was smaller. The preparation method may have caused partial aggre-
gation or oligomerization.
The value of Rg found in the static SAXS of the present study is similar to those reported previously21–24. As 
has been discussed, it is much larger than Rg values typically found in a globular protein with a similar molec-
ular weight. For example, lysozyme, which was used for a calibration purpose in this study, gives an Rg value of 
1.5–1.6 nm. This is taken as evidence that α -syn is partially unfolded in solution. However, there is a considerable 
variation in the reported Rg values which may be partially due to different buffer conditions. In the present study, 
we used two buffer conditions. One is the AA buffer with low ionic strength which was used by Bartels et al.12 
in studies on human RBC α -syn. The other is a more widely used high ionic strength Tris buffer. The Rg value 
of the recombinant WT α -syn in the AA buffer was found to be much smaller than that in the Tris buffer (2.72 
compared to 4.27 nm in the Tris buffer), even smaller than that of RBC α -syn in both buffers. These rather elusive 
results indicate that α -syn can take different conformations depending on its chemical environment. Figure 5 
shows a comparison of Kratky plots of RBC and recombinant α -syn in the Tris buffer. It is clear that even RBC 
α -syn which has a smaller Rg is far from a compact, folded protein.
The SEC-SAXS result showed a smaller Rg value (3.59 nm) for recombinant WT α -syn than in a static meas-
urement (4.27 nm). This may be due to removal of a fraction of recombinant α -syn that is forming oligomers 
in the high-ionic strength Tris buffer. The small absorption peak at an elution volume of about 10 ml (Fig. 4a) 
was consistently observed in separate experiments. Indeed, high ionic strength buffers are generally used in 
Figure 4. (a) An elusion profile of recombinant α -syn from a size-exclusion column. The flow rate was changed 
from 0.5 to 0.2 ml/min at 12.7 ml. (b) An X-ray scattering profile of α -syn pooled around the elusion peak. The 
data in 30 frames (5 min) across the elusion peak, corresponding to 1.0 ml of elusion volume, were summed 
for the analysis. The linear region of the Guinier plot was q = 0.145 to 0.359 nm−1. The data were truncated 
at around q = 1.5 nm−1 because of the small size of the X-ray detector but plotted so as to be compared with 
Fig. 1c.
Figure 5. Kratky plots of recombinant α-syn (WT) and RBC α-syn (RBC) in the Tris buffer. 
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aggregation studies24–26. We found that addition of 150 mM NaCl to the AA buffer immediately caused aggrega-
tion. It might be possible to detect different populations with SEC-SAXS. Curtain et al. employed SEC-SAXS at 
low ionic strength and found two distinct conformations of α -syn, one with Rg smaller than 3 nm and the other 
larger than 4 nm21. It is likely that a similar variation of conformation also exists in the high ionic strength buffer. 
Giehm et al. studied fibrillation of α -syn in a high ionic strength buffer at 37 °C and separated monomer (with Rg 
of 4–5 nm) from oligomers25. For separation of different oligomers and conformations with SEC-SAXS, it is cru-
cial to find an adequate flow rate because it is unclear how quickly the equilibrium among different populations 
is reached.
In conclusion, under two different conditions (high ionic strength with a Tris buffer and low ionic strength 
with an ammonium acetate buffer), no evidence was found for the presence of a tetramer. This means that a sta-
ble tetramer of α -syn cannot be found easily ex vivo. On the other hand, it was found that the buffer conditions 
strongly affect the radius of gyration of the protein. This suggests that the nature of α -syn, such as its folding 
structure, oligomerization and aggregation, is likely to considerably depend on the environmental condition. To 
investigate the pathogenesis of Parkinson’s disease, it is important to elucidate the nature of α -syn in vivo. For this 
reason, in the study of α -syn in vitro, it is necessary to pay sufficient attention to the environmental conditions.
Methods
Purification of recombinant wild-type α-synuclein. Human wild type (WT) α -syn was expressed in 
E. coli BL21(DE3) (Novagen)27. Cells were suspended in a purification buffer (50 mM Tris-HCl (pH 7.5), 1 mM 
EDTA, 0.1 mM dithiothreitol, and 0.1 mM phenylmethylsulfonyl fluoride), disrupted using sonication, and cen-
trifuged (20,000 × g, 15 min). Streptomycin sulfate (final 2.5% (w/w)) was added to the supernatant to remove 
nucleic acids. After removal of nucleic acids by centrifugation, the supernatant was heated at 90 °C in a water bath 
for 15 min and then centrifuged. The supernatant was precipitated by addition of solid ammonium sulfate to 70% 
saturation, centrifuged, dialyzed overnight, and then applied onto a Resource-Q column (GE Healthcare) with 
50 mM Tris-HCl buffer (pH 7.5) containing 0.1 mM dithiothreitol and 0.1 mM phenylmethylsulfonyl fluoride as 
a running buffer, and eluted with a linear gradient of 0–1 M NaCl. α -syn enriched fractions (as determined by 
SDS-PAGE/Coomassie Blue analysis) were then pooled and further purified by size exclusion chromatography 
using a Superdex 200 10/300 GL column (GE Healthcare) equilibrated with 50 mM Tris-HCl (pH 7.5), 150 mM 
NaCl. Pure fractions were combined and dialyzed against deionized water at 4 °C. The purity of the protein was 
confirmed to be higher than 95% by SDS-PAGE and MALDI mass spectroscopy (Fig. 1). Sample solution was 
then flash-frozen in liquid nitrogen and lyophilized.
Purification of recombinant N-terminally acetylated α-synuclein. N-terminally acetylated α -syn 
was prepared as described14,18. The α -syn plasmid was co-expressed with the pNatB plasmid28. The two vec-
tors were co-transformed into E. coli BL21 (DE3) using media containing both ampicillin and chloramphenicol. 
Subsequent purification method was the same as the above for WT α -syn.
Blood sample collection. All experimental protocols for human samples were approved by the Ethical 
Review Board at Osaka University Graduate School of Medicine and were performed in accordance with the 
Ethical Guidelines for Clinical Research of the Ministry of Health, Labour and Welfare of Japan. Informed con-
sent was previously obtained from all human subjects. Blood (200 ml or 400 ml) was collected from a healthy vol-
unteer and white blood cells (WBCs) were depleted by Sepacell Integra CA (Asahi Kasei Medical) as the product 
manual. The flow diagram of purification of α -syn from the human RBCs is shown in Supplementary Figure S1.
Lysis of human RBCs. The WBCs-depleted blood was centrifuged at 500 × g for 15 min at 4 °C and the 
serum was removed. The pelleted RBCs were washed three times by phosphate buffer solution (PBS). Then, RBCs 
were lysed by osmotic shock by addition of an equal volume of 5 mM phosphate buffer (pH 7.5) plus protease 
inhibitor mixture (Roche Applied Science). The solution was centrifuged at 20,000 × g for 15 min at 4 °C and the 
supernatant was collected and filtered through 0.22-μ m filters.
Hemoglobin depletion. RBC-soluble extracts were Hemoglobin (Hb) -depleted on nickel-based immo-
bilized metal affinity chromatography as previously described17. Soluble extracts were loaded onto a 20-ml 
HisPrepTM FF 16/10 column (GE Healthcare).
Purification of α-syn from Hb-depleted solution. Purification method was essentially the same as 
previously described17. First purification step was ion exchange chromatography (IEX). The Hb-depleted solu-
tion was injected onto a 5-ml HiTrap Q column (GE Healthcare) equilibrated with 50 mM Tris-HCl buffer, pH 
7.5. α -Syn was eluted with a 0–1 M NaCl gradient in 50 mM Tris-HCl buffer (pH 7.5) (α -Syn eluted at ~0.30 M 
NaCl). α -syn enriched fractions (as determined by SDS-PAGE/Coomassie Blue analysis) were pooled for further 
purification by hydrophobic interaction chromatography (HIC). The pooled IEX fractions were injected onto a 
5-ml HiTrap phenyl hydrophobic interaction column (GE Healthcare) equilibrated with 50 mM phosphate buffer 
(pH 7.0), 1 M (NH4)2SO4. α -syn was eluted with a 1–0 M (NH4)2SO4 gradient in 50 mM phosphate buffer (pH 7.0) 
(α -syn eluted at ~0.75 M (NH4)2SO4). α -syn enriched fractions (as determined by SDS-PAGE/Coomassie Blue 
analysis) were pooled for further purification by size exclusion chromatography (SEC). The pooled HIC fractions 
were injected onto a Superdex 200 10/300 GL column (GE Healthcare) equilibrated with 50 mM Tris-HCl (pH 
7.5), 150 mM NaCl. Pure fractions were combined and dialyzed against appropriate solution at 4 °C. The purity of 
the solution was confirmed by SDS-PAGE and MALDI mass spectroscopy (Fig. 1a,b). It confirmed that the pro-
teins were of high enough purity and that α -syn from human RBC (RBC) was likely to be N-terminally acetylated 
in terms of molecular weight. Sample solution was kept at 4 °C.
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Circular dichroism measurements. Far-UV Circular dichroism (CD) spectra were obtained with a Jasco 
820 CD spectrophotometer as described previously27. Measurements were performed at 25 °C using a quartz 
cuvette with a 1 mm path length, and the results were expressed as mean residue ellipticity [θ ].
X-ray techniques. X-ray data were collected at a bending magnet beamline BL40B2 in SPring-8. The storage 
ring was run in a top-up mode. The X-ray beam was monochromatized with a double Si (111) monochromator 
and focused with a bent-cylindrical mirror. The X-ray energy was 12.4 keV. The energy resolution was about 
1 × 10−4. The sample-to-detector distance was 1650 mm. The flux was about 5 × 1010 photons/sec. The beam size 
was about 0.2 mm in diameter. The q-spacing was calibrated with diffraction from silver behenate (first peak at 
d = 5.84 nm). All experiments were made at 25 °C.
For static measurements, α -syn was dissolved in either the Tris buffer (50 mM Tris-HCl (pH 7.5), 150 mM 
NaCl) or the AA buffer (10 mM ammonium acetate, pH 7.4). The sample solution was contained in a cell with 
0.02 mm-thick quartz windows. The volume of the cell was about 30 μ l. The exposure time was 120 s. An image 
plate X-ray detector (RAXIS-VII, RIGAKU, Japan) with a pixel size of 100 μ m × 100 μ m was used. Multiple meas-
urements were made at two to four different protein concentrations.
For SAXS coupled with a size-exclusion column (SEC-SAXS), the protein solution was loaded onto a size 
exclusion column (Superdex 200 10/300 GL) and eluted in the Tris buffer with a pump for a SAXS measurement. 
The X-ray detector was PILATUS-100K (DECTRIS, Switzerland). About 8 mg of α -syn was loaded to the column 
and the eluted solution was passed through a polyimide microtube (LB grade, KN01-LB20, Protein Wave co., Nara, 
Japan) with a diameter of 2 mm and a wall thickness 0.1 mm for X-ray measurement at a flow rate of 0.2 ml/min. 
The UV absorption at 280 nm was continuously monitored between the column and the polyimide microtube. 
An X-ray scattering measurement at a frame rate of 10.003 sec (the exposure time 10 sec) was started when the 
protein concentration began to increase. The scattering data acquired when the protein concentration was more 
than half of the peak concentration were later summed for analysis.
Data analysis. Scattering data were averaged circularly and subjected to analysis by a software package 
PRIMUS29. The radius of gyration (Rg) and the forward scattering intensity (I(0)) were obtained from a Guinier 
plot. With each protein sample, measurements were made at more than three different concentrations for each 
batch of preparation. Rg and I(0)/c (c is concentration) were plotted against the concentration and fitted with a 
straight line to obtain values at zero concentration (Fig. 4). Mean values of Rg and I(0)/c were obtained by averag-
ing the zero concentration values from different preparations.
The forward scattering intensity of α -syn was evaluated by comparison with that from hen egg lysozyme 
(six-times crystallized, Seikagaku-Kogyo, Japan), which has a molecular weight (14.3 kDa) similar to α -syn. 
Measurements were made at more than three concentrations of lysozyme and I(0)/c at zero concentration was 
obtained.
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